Xospata 40 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FWKCN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,978
Award facts
- Contract value 100% obligated
- $17,977.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,977.94 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of XOSPATA 40 mg tablets (90-unit quantity), with completion targeted for September 10, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed-price delivery order arrangement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the federal medical supply chain, with an extensive portfolio of federal contract awards primarily supporting the Defense Logistics Agency and military healthcare systems. The company's contract performance demonstrates versatility across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices that support the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This particular delivery order for XOSPATA, an oncology medication, reflects the company's ongoing role in supplying specialized pharmaceutical products to federal healthcare customers through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DB25FWKCN?
SPE2DB25FWKCN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FWKCN worth?
The government has obligated $17,978 on SPE2DB25FWKCN.
Is contract SPE2DB25FWKCN an order under another contract?
Yes. SPE2DB25FWKCN is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKCN competed?
The extent of competition for SPE2DB25FWKCN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award